Clinical Trial Update: Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for denosumab in bisphosphonate-naive metastatic breast cancer; the study was completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer, Metastases | Phase 2 | Status: COMPLETED | Results posted: 2011-01-07